Key result
Newer oral anticoagulation agents for atrial fibrillation present novel clinical management conundrums.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to novel AF anticoagulation challenges; leaves open optimal strategies for prospective study.
Click here to view the Original article by Dr. Staerk et al .
No takes yet. Share an insight, caveat, or question.
Leggio et al. (2018) studied this question. Newer oral anticoagulation agents for atrial fibrillation present novel clinical management conundrums.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: